Carretero et al.35, Arnold et al.17, and Reichman et al.16 all reporting anti-tumor activity of eosinophils against CRC cells, though only16 report a direct effect and Carretero et al.35 and Arnold et al.17 suggest a CD8+ lymphocyte recruitment as the anti-tumor measure. The gene discussed is CD8A; the disease is neoplasm.